412 related articles for article (PubMed ID: 18171992)
41. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
42. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development.
Lee H; Kim M; Baek M; Morales LD; Jang IS; Slaga TJ; DiGiovanni J; Kim DJ
Sci Rep; 2017 Mar; 7():45077. PubMed ID: 28322331
[TBL] [Abstract][Full Text] [Related]
43. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.
Lee JC; Kundu JK; Hwang DM; Na HK; Surh YJ
Carcinogenesis; 2007 Jul; 28(7):1491-8. PubMed ID: 17372274
[TBL] [Abstract][Full Text] [Related]
44. Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion.
Hansen LA; Monteiro-Riviere NA; Smart RC
Cancer Res; 1990 Sep; 50(18):5740-5. PubMed ID: 2393848
[TBL] [Abstract][Full Text] [Related]
45. Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.
Ikuta S; Edamatsu H; Li M; Hu L; Kataoka T
Cancer Res; 2008 Jan; 68(1):64-72. PubMed ID: 18172297
[TBL] [Abstract][Full Text] [Related]
46. Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction.
Chen N; Ma WY; She QB; Wu E; Liu G; Bode AM; Dong Z
J Biol Chem; 2001 Dec; 276(50):46722-8. PubMed ID: 11592962
[TBL] [Abstract][Full Text] [Related]
47. Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Checkley LA; Rho O; Moore T; Hursting S; DiGiovanni J
Cancer Prev Res (Phila); 2011 Jul; 4(7):1011-20. PubMed ID: 21733825
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice.
Wilker E; Bol D; Kiguchi K; Rupp T; Beltrán L; DiGiovanni J
Mol Carcinog; 1999 Jun; 25(2):122-31. PubMed ID: 10365914
[TBL] [Abstract][Full Text] [Related]
49. The effect of plant phenols on the expression and activity of phorbol ester-induced PKC in mouse epidermis.
Szaefer H; Kaczmarek J; Rybczyńska M; Baer-Dubowska W
Toxicology; 2007 Jan; 230(1):1-10. PubMed ID: 17196728
[TBL] [Abstract][Full Text] [Related]
50. Effect of 12-O-tetradecanoylphorbol-13-acetate on inhibition of expression of keratin 1 mRNA in mouse keratinocytes mimicked by 12(S)-hydroxyeicosatetraenoic acid.
Hagerman RA; Fischer SM; Locniskar MF
Mol Carcinog; 1997 Jul; 19(3):157-64. PubMed ID: 9254882
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Jun; 63(12):3037-42. PubMed ID: 12810623
[TBL] [Abstract][Full Text] [Related]
52. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin.
Lee JY; Shin JW; Chun KS; Park KK; Chung WY; Bang YJ; Sung JH; Surh YJ
Carcinogenesis; 2005 Feb; 26(2):359-67. PubMed ID: 15498788
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-alpha, and skin tumor promotion in wa-1 mice.
Kiguchi K; Beltrán L; Dubowski A; DiGiovanni J
J Invest Dermatol; 1997 May; 108(5):784-91. PubMed ID: 9129233
[TBL] [Abstract][Full Text] [Related]
54. The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.
Arun SN; Xie D; Dodd ME; Zhong X; Bollag WB
J Dermatol Sci; 2010 Oct; 60(1):29-39. PubMed ID: 20832999
[TBL] [Abstract][Full Text] [Related]
55. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
Yan S; Wenner CE
J Cell Physiol; 2001 Mar; 186(3):338-49. PubMed ID: 11169972
[TBL] [Abstract][Full Text] [Related]
56. Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis.
Gupta AK; Fisher GJ; Elder JT; Talwar HS; Esmann J; Duell EA; Nickoloff BJ; Voorhees JJ
J Invest Dermatol; 1989 Sep; 93(3):379-86. PubMed ID: 2570112
[TBL] [Abstract][Full Text] [Related]
57. Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.
Segrelles C; Lu J; Hammann B; Santos M; Moral M; Cascallana JL; Lara MF; Rho O; Carbajal S; Traag J; Beltrán L; Martínez-Cruz AB; García-Escudero R; Lorz C; Ruiz S; Bravo A; Paramio JM; DiGiovanni J
Cancer Res; 2007 Nov; 67(22):10879-88. PubMed ID: 18006833
[TBL] [Abstract][Full Text] [Related]
58. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.
Xia W; Mullin RJ; Keith BR; Liu LH; Ma H; Rusnak DW; Owens G; Alligood KJ; Spector NL
Oncogene; 2002 Sep; 21(41):6255-63. PubMed ID: 12214266
[TBL] [Abstract][Full Text] [Related]
59. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
[TBL] [Abstract][Full Text] [Related]
60. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
